Literature DB >> 15005590

Optical coherence tomography and retinal thickness analyzer features of spontaneous resolution of vitreomacular traction syndrome: a case report.

P Carpineto1, M Ciancaglini, A Aharrh-Gnama, L Agnifili, L Mastropasqua.   

Abstract

PURPOSE: To report optical coherence tomography (OCT) and retinal thickness analyzer (RTA) findings in a case of spontaneous resolution of vitreomacular traction syndrome.
METHODS: Qualitative and quantitative analysis of the macular region was performed with OCT and RTA.
RESULTS: In the left eye of a 34-year-old woman with blurred vision, OCT and RTA examination showed a discrete linear signal anterior to the retina with attachment at the macula and secondary cystoid macular changes. OCT and RTA examination showed an increase in macular thickness (350 microm). Six months later the patient showed a spontaneous complete recovery of visual acuity. Vitreomacular traction and cystoid changes were no longer detectable at OCT and RTA examination; retinal thickness was normal (205 microm) and a posterior vitreous detachment was visible.
CONCLUSIONS: Both OCT and RTA were useful tools for making the diagnosis of vitreomacular traction syndrome and demonstrating the effect of spontaneous vitreomacular traction release with resolution of cystoid macular changes.

Entities:  

Mesh:

Year:  2004        PMID: 15005590     DOI: 10.1177/112067210401400113

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

1.  Spontaneous resolution of idiopathic vitreomacular traction syndrome in a healthy young man.

Authors:  Zhen Wang; Xiao Lv; Mingfeng Wu; Wei Xu; Ao Rong
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Advanced Morphological and Functional Magnetic Resonance Techniques in Glaucoma.

Authors:  Rodolfo Mastropasqua; Luca Agnifili; Peter A Mattei; Massimo Caulo; Vincenzo Fasanella; Riccardo Navarra; Leonardo Mastropasqua; Giorgio Marchini
Journal:  Biomed Res Int       Date:  2015-06-08       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.